Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Galectin-3 enhances cyclin D1 promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells

Abstract

Galectin-3 is a multifunctional carbohydrate-binding protein found in the nucleus, cytoplasm and the extracellular milieu. Nuclear galectin-3 expression is associated with cell proliferation, and its role in pre-mRNA splicing has been suggested. In this report, we investigated the role of galectin-3 on cyclin D1 gene expression, a critical inducer of the cell cycle and a potential oncogene in human cancer. We found that galectin-3 induces cyclin D1 promoter activity in human breast epithelial cells independent of cell adhesion through multiple cis-elements, including the SP1 and CRE sites. We present evidence that galectin-3 induction of the cyclin D1 promoter may result from enhancement/stabilization of nuclear protein-DNA complex formation at the CRE site of the cyclin D1 promoter. We also show that galectin-3 co-operates with, but does not depend on, pRb for cyclin D1 promoter activation. The present study reveals a growth promoting activity of galectin-3 through cyclin D1 induction, and suggests a novel function of nuclear galectin-3 in the regulation of gene transcription.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

Abbreviations

The abbreviations used are: PBS:

phosphate-buffered saline

CDK:

cyclin-dependent kinase

CRE:

cAMP-responsive element

CREB:

cAMP-responsive element binding protein

SDS:

sodium dodecyl sulfate

PMSF:

phenylmethylsulfonyl fluoride

IPTG:

isopropylthio-β-D-galactoside

References

  • Akahani S, Nangia-Makker P, Inohara H, Kim HR, Raz A . 1997 Cancer Res. 57: 5272–5276

  • Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A, Pestell RG . 1995 J. Biol. Chem. 270: 23589–23597

  • Bienvenu F, Gascan H, Coqueret O . 2001 J. Biol. Chem. 276: 16840–16847

  • Bresalier RS, Yan PS, Byrd JC, Lotan R, Raz A . 1997 Cancer 80: 776–787

  • Dagher SF, Wang JL, Patterson RJ . 1995 Proc. Natl. Acad. Sci. USA 92: 1213–1217

  • D'Amico M, Hulit J, Amanatullah DF, Zafonte BT, Albanese C, Bouzahzah B, Fu M, Augenlicht LH, Donehower LA, Takemaru K, Moon RT, Davis R, Lisanti MP, Shtutman M, Zhurinsky J, Ben-Ze'ev A, Troussard AA, Dedhar S, Pestell RG . 2000 J. Biol. Chem. 275: 32649–32657

  • Goodrich DW, Wang NP, Qian YW, Lee EY, Lee WH . 1991 Cell 67: 293–302

  • Guttridge DC, Albanese C, Reuther JY, Pestell RG, Baldwin AS . 1999 Mol. Cell. Biol. 19: 5785–5799

  • Hinz M, Krappmann D, Eichten A, Heder A, Scheidereit C, Strauss M . 1999 Mol. Cell. Biol. 19: 2690–2698

  • Joyce D, Bouzahzah B, Fu M, Albanese C, d'Amico M, Steer J, Klein JU, Lee RJ, Segall JE, Westwick JK, Der CJ, Pestell RG . 1999 J. Biol. Chem. 274: 25245–25249

  • Kadrofske MM, Openo KP, Wang JL . 1998 Arch. Biochem. Biophys 349: 7–20

  • Kim HR, Lin HM, Biliran H, Raz A . 1999 Cancer Res. 59: 4148–4154

  • Kim SJ, Onwuta US, Lee YI, Li R, Botchan MR, Robbins PD . 1992 Mol. Cell. Biol. 12: 2455–2463

  • Konstantinov KN, Robbins BA, Liu FT . 1996 Am. J. Pathol. 148: 25–30

  • Latella L, Sacco A, Pajalunga D, Tiainen M, Macera D, d'Angelo M, Felici A, Sacchi A, Crescenzi M . 2001 Mol. Cell. Biol. 21: 5631–5643

  • Lavoie JN, l'Allemain G, Brunet A, Muller R, Pouyssegur J . 1996 J. Biol. Chem. 271: 20608–20616

  • Le Gall M, Grall D, Chambard JC, Pouyssegur J, Van Obberghan-Schilling E . 1998 Oncogene 17: 1271–1277

  • Le Marer N, Hughes RC . 1996 J. Cell. Physiol. 168: 51–58

  • Lee RJ, Albanese C, Stenger RJ, Watanabe G, Inghirami G, Haines GK, Webster M, Muller WJ, Brugge JS, Davis RJ, Pestell RG . 1999 J. Biol. Chem. 274: 7341–7350

  • Lin HM, Moon BK, Yu F, Kim HR . 2000 Carcinogenesis 21: 1941–1945

  • Lin HM, Ruiz-Carrillo A, Dodgson JB . 1998 DNA Cell Biol. 17: 197–206

  • Lotan R, Ito H, Yasui W, Yokozaki H, Lotan D, Tahara E . 1994 Int. J. Cancer 56: 474–480

  • Lukas J, Bartkova J, Rohde M, Strauss M, Bartek J . 1995 Mol. Cell. Biol. 15: 2600–2611

  • Matarrese P, Fusco O, Tinari N, Natoli C, Liu FT, Semeraro ML, Malorni W, Iacobelli S . 2000 Int. J. Cancer 85: 545–554

  • Matarresea P, Tinari N, Semeraroa ML, Natolib C, Iacobelli S, Malorni W . 2000 FEBS Lett. 473: 311–315

  • Matsumura I, Kitamura T, Wakao H, Tanaka H, Hashimoto K, Albanese C, Downward J, Pestell RG, Kanakura Y . 1999 EMBO J. 18: 1367–1377

  • Motokura T, Arnold A . 1993 Curr. Opin. Genet. Dev. 3: 5–10

  • Nagata D, Suzuki E, Nishimatsu H, Satonaka H, Goto A, Omata M, Hirata Y . 2001 J. Biol. Chem. 276: 662–669

  • Nangia-Makker P, Sarvis R, Visscher DW, Bailey-Penrod J, Raz A, Sarkar FH . 1998 Breast Cancer Res. Treat. 49: 171–183

  • Openo KP, Kadrofske MM, Patterson RJ, Wang JL . 2000 Exp. Cell Res. 255: 278–290

  • Pestell RG, Albanese C, Reutens AT, Segall JE, Lee RJ, Arnold A . 1999 Endocr. Rev. 20: 501–534

  • Philipp A, Schneider A, Vasrik I, Finke K, Xiong Y, Beach D, Alitalo K, Eilers M . 1994 Mol. Cell. Biol. 14: 4032–4043

  • Pines J . 1995 Biochem. J. 308: 697–711

  • Raz A, Pazerini G, Carmi P . 1989 Cancer Res. 49: 3489–3493

  • Resnitzky D, Reed SI . 1995 Mol. Cell. Biol. 15: 3463–3469

  • Sato S, Hughes RC . 1992 J. Biol. Chem. 267: 6983–6990

  • Sherr CJ . 1994 Cell 79: 551–555

  • Wang L, Inohara H, Pienta KJ, Raz A . 1995 Biochem. Biophys. Res. Commun. 217: 292–303

  • Watanabe G, Albanese C, Lee RJ, Reutens A, Vairo G, Henglein B, Pestell RG . 1998 Mol. Cell. Biol. 18: 3212–3222

  • Watanabe G, Howe A, Lee RJ, Albanese C, Shu IW, Karnezis AN, Zon L, Kyriakis J, Rundell K, Pestell RG . 1996a Proc. Natl. Acad. Sci. USA 93: 12861–12866

  • Watanabe G, Lee RJ, Albanese C, Rainey WE, Batlle D, Pestell RG . 1996b J. Biol. Chem. 271: 22570–22577

  • Weinberg RA . 1995 Cell 81: 323–330

  • Yang RY, Hsu DK, Liu FT . 1996 Proc. Natl. Acad. Sci. USA 93: 6737–6742

  • Yoshii T, Fukumori T, Honjo Y, Inohara H, Kim HR, Raz A . 2002 J. Biol. Chem. 277: 6852–6857

  • Yu F, Finley Jr RL, Raz A, Kim HR . 2002 J. Biol. Chem. 277: 15819–15827

  • Zhao JH, Reiske H, Guan JL . 1998 J. Cell Biol. 143: 1997–2008

  • Zhu X, Ohtsubo M, Bohmer RM, Roberts JM, Assoian RK . 1996 J. Cell Biol. 133: 391–403

Download references

Acknowledgements

We thank Dr Fei Yu, Dr Kamiar Moin and Ms Linda Mayernik for helping with confocal microscopic analysis, and Dr Xu-Wen Liu, Dr Ki-Kyung Jung, and Ms Mary Ann Krug for helping with the preparation of the manuscript. Supported in part by NIH/NCI (CA-64139) and DOD (DAMD17-99-1-9442) grants to H-RC Kim, and NIH/NCI (CA-46120) to AR.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hyeong-Reh Choi Kim.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lin, HM., Pestell, R., Raz, A. et al. Galectin-3 enhances cyclin D1 promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells. Oncogene 21, 8001–8010 (2002). https://doi.org/10.1038/sj.onc.1205820

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205820

Keywords

This article is cited by

Search

Quick links